Healthcare & Life Sciences

FDA Draft Guidance Q&A on Food Traceability Records

The FDA has issued draft guidance in a Q&A format to help industry understand the requirements for additional traceability records for certain foods, as established by a final rule in 2022. Comments on this draft guidance are due by May 21, 2026.

FDA Guidance on Antimicrobial Drug Durations for Food Animals

The FDA's Center for Veterinary Medicine has issued guidance for sponsors of new animal drug applications concerning medically important antimicrobial drugs used in food-producing animals. The guidance aims to facilitate voluntary changes to define durations of use for these drugs to mitigate antimicrobial resistance.

HHS OIG: Sarasota Memorial Hospital Medicare Overpayments Total $12.1 Million

The HHS Office of Inspector General (OIG) found that Sarasota Memorial Hospital received at least $12.1 million in Medicare overpayments between January 1, 2020, and December 31, 2021. The OIG recommended the hospital refund the overpaid amount and implement additional training.

HHS OIG Report: Alaska Missed Foster Care Opportunities for Native Children

The HHS Office of Inspector General issued a report finding that Alaska missed opportunities to protect American Indian and Alaska Native children missing from foster care. The report details failures in notification, follow-up actions, sex trafficking assessments, caseworker visits, and tribal communication, recommending improvements supported by ACF.

EMA Recommends Six New Medicines for Approval

The European Medicines Agency's CHMP has recommended six new medicines for marketing authorisation and nine for extension of therapeutic indications. These recommendations cover treatments for various conditions including menopausal symptoms, liver disease, a rare genetic disorder, influenza, and graft-versus-host disease.

EMA Recommends Kygevvi for Rare TK2d Disease Treatment

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Kygevvi, a new treatment for the rare genetic disease thymidine kinase 2 deficiency (TK2d). This recommendation is based on clinical study data showing improvement in motor function for pediatric patients.

EMA Recommends Withdrawal of Levamisole Medicines

The European Medicines Agency (EMA) recommends the withdrawal of marketing authorisations for medicines containing levamisole due to the serious side effect of leukoencephalopathy. This recommendation follows an EU-wide review concluding that the benefits of these medicines no longer outweigh their risks for treating parasitic worm infections.

Levamisole withdrawn from EU market due to leukoencephalopathy risk

The EMA's PRAC has recommended the withdrawal of marketing authorisations for all medicines containing levamisole from the EU market. This decision is due to the confirmed risk of leukoencephalopathy, a serious brain side effect, where the benefits of the medicine no longer outweigh the risks for treating parasitic worm infections.

CVMP Opinions and Guidelines Update

The EMA's Committee for Veterinary Medicinal Products (CVMP) adopted positive opinions for several variations to existing veterinary medicinal products and discussed pharmacovigilance signals. These updates primarily involve product information changes based on signal management processes.

State Revokes, Suspends Health Care Provider Licenses

The Washington State Department of Health has revoked or suspended the licenses, certifications, or registrations of two health care providers. Elena T. Nguyen had her nursing assistant credentials suspended for two years due to drug use with a minor, and Kyon J. Saucier had his home care aide credential indefinitely suspended for physical force on children.

HHS OIG: 14 Providers Improperly Claimed $70.6M in PRF Payments

The HHS Office of Inspector General (OIG) reported that 14 out of 30 selected Indian Health Service and rural providers did not comply with terms and conditions for expending $70.6 million in Provider Relief Fund (PRF) payments. The OIG recommended that HRSA require these providers to return unallowable expenditures.

HHS OIG Audit of Utah Capitation Payments

The HHS Office of Inspector General (OIG) has issued an audit report, in partnership with the Utah Inspector General, concerning capitation payments made concurrently with another state. The report, dated February 20, 2026, details findings related to Medicaid payments.

State Disciplines Health Care Providers for Misconduct

The Washington State Department of Health has disciplined six healthcare providers for misconduct and substance use. Actions include denial of applications, charges of unprofessional conduct, and agreed orders to cease practice, with one provider fined $500.

Washington State Health Provider License Actions

The Washington State Department of Health has revoked or suspended the licenses, certifications, or registrations of six health care providers. These actions were taken due to various violations including neglect of vulnerable adults, submitting false information, and patient care issues.

State Disciplines Healthcare Providers

The Washington State Department of Health has taken disciplinary actions against 11 healthcare providers, including denying applications, charging with unprofessional conduct, and placing credentials on probation. These actions are based on convictions, failure to comply with stipulations, and other professional misconduct.

Missouri Failed to Collect $12.2M in Medicaid Drug Rebates

The HHS Office of Inspector General (OIG) found that Missouri failed to collect $12.2 million in federal rebates for Medicaid physician-administered and pharmacy drugs between January 1, 2019, and December 31, 2022. The OIG recommends Missouri refund the federal government $9.7 million for physician-administered drugs and $2.5 million for pharmacy drugs.

State Revokes/Suspends Health Care Provider Licenses

The Washington State Department of Health has revoked or suspended the licenses, certifications, or registrations of four health care providers due to findings of neglect or abuse of vulnerable adults. These actions prohibit the individuals from practicing or having unsupervised access to vulnerable populations.

ACF Contract for Unaccompanied Alien Children Services Noncompliant

The HHS OIG found that the Administration for Children and Families (ACF) awarded a $529 million sole source contract for unaccompanied alien children services in a noncompliant manner. The contract was double the cost estimate and lacked required pre-award documentation.

HHS OIG: West Virginia Failed to Collect $6.1M in Medicaid Drug Rebates

The HHS Office of Inspector General found that West Virginia failed to collect an estimated $6.1 million in federal rebates for physician-administered drugs dispensed to Medicaid managed-care enrollees. The audit identified failures in internal controls that prevented the state from invoicing manufacturers for these rebates.

Pharmacist Robert E Jennings Jr Discipline on File

The Florida Department of Health has a disciplinary action on file for Pharmacist Robert E Jennings Jr. The license verification indicates a public complaint and disciplinary action are present, requiring further review by clicking the relevant tabs. This information is publicly available as of February 18, 2026.

Pharmacist Karen M Small Discipline and Public Complaint Record

The Florida Department of Health has updated the public record for pharmacist Karen M Small, indicating that discipline and a public complaint are on file. The data was last updated on February 18, 2026, and her license is active until September 30, 2027.

Pharmacist Frank Spadaccini Faces Disciplinary Action

The Florida Department of Health is taking disciplinary action against pharmacist Frank Spadaccini, license number PS39752. The license verification data indicates disciplinary action is on file and a public complaint has been filed.

State of Florida Pharmacist License Discipline Record

The State of Florida Department of Health has updated the license verification for Pharmacist Traniece Fullwood, indicating a discipline action is on file. This update signifies a change in the professional standing of the licensee.

Pharmacist John Laud-Hammond Faces Discipline

The Florida Department of Health has imposed disciplinary obligations on pharmacist John Laud-Hammond. The license verification indicates 'Discipline on File' and 'Public Complaint' are present, requiring further review of specific actions taken.

King County Massage Therapist Credential Suspended for Sexual Misconduct

Washington State health officials have suspended the credential of King County massage therapist Matthew McQuain pending further legal action due to allegations of sexual assault against two clients. The suspension prohibits him from practicing in Washington to protect public safety. McQuain has 20 days to request a hearing.

Washington State Disciplines Healthcare Providers

The Washington State Department of Health has taken disciplinary actions against 14 healthcare providers in February 2026. These actions include denying applications for credentials and rescinding previously issued credentials due to violations and professional misconduct.

State Revokes, Suspends Health Care Provider Licenses

The Washington State Department of Health has revoked or suspended the licenses, certifications, or registrations of eight health care providers due to misconduct, including financial exploitation of vulnerable adults and practicing under the influence. Some providers also face fines and indefinite suspension of credentials.

King County Massage Therapist License Suspended

Washington State health officials have suspended the license of King County massage therapist Jason Senat pending further legal action. The suspension follows charges alleging sexual assault of four clients and is intended to protect patient safety. Senat has the option to request a hearing to contest the charges.

Washington DOH Disciplines Healthcare Providers

The Washington State Department of Health has taken disciplinary actions against nine healthcare providers for misconduct, including unprofessional conduct, financial exploitation, and unlicensed practice. These actions range from charges and investigations to denial of credentials and termination of probation.

Pharmacy Commission Meeting Minutes and Actions

The Connecticut Commission of Pharmacy met on October 30, 2024, approving a new pharmacy application with modifications, a pharmacy remodel, and issuing fines totaling $3,000 to Walgreens for violations related to pharmacy closures and compounding standards. The commission also approved reciprocity and new applications.

Pharmacy Commission Meeting Agenda - October 30, 2024

The Connecticut Pharmacy Commission meeting agenda for October 30, 2024, outlines discussions on new pharmacy applications, remodels, pharmacy manager appointments, and reciprocity interviews. The agenda also includes requests for new non-resident pharmacy applications and updates on previously approved or denied applications.

Pharmacy Commission Meeting Minutes - Approvals and Enforcement

The Connecticut Commission of Pharmacy approved new pharmacy premises and several pharmacy remodels during its November 20, 2024 meeting. The Commission also initiated an enforcement action against Walgreens #02410 for alleged violations related to pharmacy manager changes and operating without a manager.

Pharmacy Commission Meeting Agenda

The Connecticut Pharmacy Commission met on November 20, 2024, to review 20 new pharmacy applications, including new and non-resident pharmacies, and address two legal cases. The agenda also included discussions on pharmacy remodels and reciprocity interviews.

Connecticut Commission of Pharmacy Meeting Schedule

The Connecticut Commission of Pharmacy has published its upcoming meeting dates and locations for 2024-2026. These notices provide details on regular meeting times, locations, and links to agendas and minutes for public review.

Virginia Board of Pharmacy Staffing Concerns and Statewide Protocols Update

The Virginia Board of Pharmacy has updated its guidance on reporting pharmacy staffing concerns and has amended several statewide protocols for pharmacists. Pharmacy permit holders must review and act on staffing reports, and pharmacists can report issues directly to the board without fear of retaliation. The revised protocols cover vaccinations, tuberculosis testing, hormonal contraceptives, naloxone, influenza, and strep throat.

Virginia Pharmacy Technician Registration Requirements Updated

The Virginia Board of Pharmacy is implementing new registration requirements for pharmacy technicians, effective July 1, 2025. Individuals will need to complete an accredited training program or equivalent and pass a national certification exam to be registered.

Virginia Pharmacy Law and Regulatory Updates

The Virginia Board of Pharmacy presented updates on recent legislative and regulatory changes affecting pharmacy practice. Key changes include expanded educational standards for pharmacy technicians and new provisions for collaborative practice agreements allowing pharmacists to prescribe certain controlled substances.

Virginia Board of Pharmacy Revised Online PIC Change Process

The Virginia Board of Pharmacy has implemented a revised, entirely online process for completing a change of pharmacist-in-charge (PIC) for pharmacy permits. This update includes electronic payment via credit card and requires uploading a one-page document to finalize the request. A revised Pharmacy Permit Application Form is also now in use for other changes.

Virginia Board of Pharmacy Legislative and Regulatory Updates

The Virginia Board of Pharmacy has updated its regulations regarding pharmacy technician education standards and collaborative practice agreements. Key changes include expanded options for technician training and clarified processes for pharmacists to obtain DEA registration for prescribing controlled substances.

Massachusetts: 90-day Supply for Certain Schedule II/III Prescriptions

The Massachusetts Board of Registration in Pharmacy updated its policy to allow a 90-day supply for certain Schedule II and III prescriptions, including those for opioid use disorder treatment, non-opioid stimulants, testosterone, and implantable infusion pumps. Other Schedule II and III medications remain limited to a 30-day supply.

MA Board Adopts Rapid Microbial Methods for Sterility Testing

The Massachusetts Board of Registration in Pharmacy has adopted a new policy allowing the use of Rapid Microbial Methods (RMMs) as an alternative for sterility release testing of compounded sterile preparations (CSPs). This policy outlines requirements for licensed sterile compounding pharmacies to ensure public safety when using these advanced technologies.

Rapid Microbial Methods Sterility Testing Guidance

The Massachusetts Department of Public Health has issued guidance on the use of Rapid Microbial Methods (RMMs) for sterility testing. This document outlines acceptable approaches and considerations for implementing RMMs in pharmaceutical and medical device manufacturing.

Massachusetts Pharmacy Practice Definitions

The Massachusetts Board of Registration in Pharmacy has issued a document defining key terms related to pharmacy practice. This guidance aims to clarify terminology for pharmacists and related entities operating within the state.

Pharmacy Policy: Definitions for Automated Dispensing, Compounding, and Events

The Massachusetts Board of Registration in Pharmacy has adopted Policy 2025-02, defining key terms related to automated dispensing devices, automated pharmacy systems, pharmacy processing automation, quality-related events, and serious adverse drug events. These definitions clarify regulatory expectations for pharmacies operating in the state.

Illinois Department of Financial and Professional Regulation January 2025 Enforcement Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in January 2025. Actions include the FDIC taking control of Pulaski Savings Bank, consent orders for various financial institutions, and license suspensions or cease and desist orders for unlicensed practices and professional misconduct.

Illinois IDFPR May 2025 Enforcement Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in May 2025 against 21 individuals and 7 companies. Actions include license revocations, consent orders, settlements, and civil penalties for violations of various financial and professional regulations.

Illinois Department of Financial and Professional Regulation Enforcement Actions April 2025

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in April 2025 against 31 individuals and 10 companies. Actions include consent orders, settlements, and license suspensions related to violations of various state acts.

IDFPR February 2025 Enforcement Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in February 2025 against 30 entities. Actions include license suspensions, consent orders for violations of various acts, and settlements for late renewal payments.

Illinois March 2025 Disciplinary Actions

The Illinois Department of Financial and Professional Regulation (IDFPR) announced enforcement actions taken in March 2025. Actions include consent orders for unlicensed activity, late renewal payments, reciprocal discipline, and settlements for violations of various acts. Several professional licenses were suspended for failure to pay state income taxes or child support.

California Board of Pharmacy News Roundup - August 2025

The California Board of Pharmacy issued a news roundup for August 2025, providing updates on Rite Aid closures, emergency refills, medication error reporting requirements effective September 1, 2025, and a new online portal for drug theft/loss reporting. A new Pharmacist-in-Charge training webinar is also available.